Unnati Pharmax

MYHEP LVIR Ledipasvir and Sofosbuvir Tablets – Breakthrough Therapy for Hepatitis C
Brand: MYHEP LVIR
Generic Name: Ledipasvir and Sofosbuvir
Strength: Ledipasvir 90 mg + Sofosbuvir 400 mg
Form: Oral Tablets
Manufacturer: Mylan
Availability: In Stock | Ships Worldwide
Exported by: Unnati Pharmax

Product Overview

MYHEP LVIR is a potent, once-daily oral antiviral combination used in the treatment of chronic hepatitis C virus (HCV) infection, specifically genotype 1. Therapeutically equivalent to the globally recognized brand Harvoni, MYHEP LVIR combines two direct-acting antiviral agents—Ledipasvir and Sofosbuvir—that work synergistically to suppress viral replication and help achieve sustained virologic response (SVR).

This fixed-dose combination has revolutionized HCV treatment by providing interferon-free therapy with high cure rates, short duration, and minimal side effects.

Why Choose MYHEP LVIR Ledipasvir and Sofosbuvir?

✅ Proven high cure rates for genotype 1 HCV infections
✅ Direct-acting antivirals with synergistic mechanism
✅ Once-daily oral dosing improves compliance
✅ Interferon- and ribavirin-free regimen
✅ Widely used in liver clinics and gastroenterology practices worldwide

How It Works

Ledipasvir is an NS5A inhibitor and Sofosbuvir is an NS5B polymerase inhibitor. Together, they disrupt the replication cycle of the hepatitis C virus, blocking both viral RNA replication and protein synthesis. This dual mechanism allows for rapid reduction in viral load and promotes liver healing.

Composition

Each tablet contains:

• Ledipasvir 90 mg

• Sofosbuvir 400 mg

Dosage and Administration

Take MYHEP LVIR exactly as prescribed by your physician:

• Recommended Dose: One tablet once daily

• May be taken with or without food

• Swallow whole with water; do not chew or crush

Buy MYHEP LVIR Tablets Online

Looking to source premium-quality Ledipasvir and Sofosbuvir tablets? Order MYHEP LVIR today from Unnati Pharmax, your trusted global exporter of antiviral and specialty medicines. We provide:

✅ 100% genuine products
✅ Express global shipping
✅ Discreet packaging for privacy
✅ Competitive prices for retail and wholesale

FAQs – MYHEP LVIR Ledipasvir and Sofosbuvir Tablets

Q1: What is MYHEP LVIR used for?
A1: MYHEP LVIR is used to treat chronic hepatitis C virus infection, particularly genotype 1.

Q2: Is MYHEP LVIR equivalent to Harvoni?
A2: Yes, MYHEP LVIR contains the same active ingredients and strength as Harvoni, making it therapeutically equivalent.

Q3: How long is the typical treatment duration with MYHEP LVIR?
A3: Treatment usually lasts 8 to 12 weeks, depending on your HCV genotype, viral load, and treatment history.

🛒 Order MYHEP LVIR Now – Exclusively from Unnati Pharmax, Your Global Partner for Affordable Hepatitis C Treatment.

Nab Paclitero 100mg Injection – Paclitaxel (Protein-Bound) 100mg | Generic Abraxane

Active Ingredient: Paclitaxel (Albumin-bound Nanoparticle Suspension)
Strength: 100mg
Brand Equivalent: Abraxane®
Form: Lyophilized Powder for Injection
Therapeutic Class: Anticancer – Microtubule Inhibitor
Manufacturer: [Manufacturer Name]
Exported By: Unnati Pharmax

📄 Product Overview

Nab Paclitero 100mg Injection contains Paclitaxel (Protein-bound nanoparticle formulation)—a chemotherapy medication used for the treatment of advanced or metastatic cancers. It is a high-quality generic equivalent of Abraxane®, providing similar efficacy and safety at a significantly lower global procurement cost.

Unlike conventional paclitaxel, Nab Paclitaxel is solvent-free, eliminating the need for premedication with steroids or antihistamines and improving safety and tolerability. This formulation offers superior tumor penetration with enhanced clinical outcomes in breast cancer, lung cancer, and pancreatic cancer.

Manufactured under strict WHO-GMP standards, Nab Paclitero is an export-grade oncology product trusted by hospitals and cancer centers worldwide.

⭐ Key Features

✅ Albumin-bound nanoparticle formulation (no solvents)
✅ Equivalent efficacy to Abraxane®
✅ Higher tumor delivery & better tolerability than standard paclitaxel
✅ No requirement for steroid premedication
✅ Suitable for metastatic and recurrent cancers
✅ Export-quality, globally accepted formulation
✅ Used in both monotherapy and combination therapy

💊 Indications & Uses

Nab Paclitero 100mg Injection is prescribed for:

✔ Metastatic Breast Cancer (after failure of first-line therapy)
✔ Non-Small Cell Lung Cancer (NSCLC) – in combination with carboplatin
✔ Metastatic Adenocarcinoma of the Pancreas – with gemcitabine
✔ Tumors requiring solvent-free paclitaxel for safety/tolerance reasons

⚙ Mechanism of Action

Paclitaxel works by:

🔹 Stabilizing microtubules
🔹 Preventing cancer cell division
🔹 Triggering apoptosis (programmed cell death)

The albumin-bound nanoparticle technology enhances delivery directly into tumor tissue using the natural albumin receptor (gp60), improving therapeutic outcomes.

⚠ Dosage & Administration

• Administered intravenously (IV) only
• Dose determined based on Body Surface Area (BSA)
• Typical regimens:
– Breast cancer: 260 mg/m² every 3 weeks
– NSCLC: 100 mg/m² weekly
– Pancreatic cancer: 125 mg/m² weekly (3 weeks on + 1 week off)
• No premedication required

📌 Must be administered under oncologist supervision in a controlled medical facility.

⚠ Side Effects

Common adverse effects include:

• Neutropenia
• Fatigue
• Nausea/vomiting
• Peripheral neuropathy
• Hair loss
• Anemia or thrombocytopenia

Severe reactions require dose adjustments and medical monitoring.

🌍 Global Export – Nab Paclitero 100mg

Unnati Pharmax supplies Nab Paclitero (Paclitaxel 100mg) internationally with:

✔ 100% authentic, GMP-certified stock
✔ Competitive wholesale prices
✔ Cold-chain compliant packaging
✔ Fast delivery to 45+ countries
✔ Support for hospitals, distributors & tenders

HEPCINAT PLUS Daclatasvir + Sofosbuvir Tablets – Dual-Action Therapy for Hepatitis CBrand: HEPCINAT PLUSGeneric Name: Daclatasvir + SofosbuvirStrength: Daclatasvir 60 mg + Sofosbuvir 400 mgForm: Oral TabletsManufacturer: Natco Pharma Ltd.Availability: In Stock | Ships WorldwideExported by: Unnati Pharmax
Product OverviewHEPCINAT PLUS Tablets combine Daclatasvir (60 mg) and Sofosbuvir (400 mg)—a powerful dual therapy approved for the treatment of chronic Hepatitis C virus (HCV) infection. This fixed-dose combination is effective against multiple genotypes (especially 1, 3, and 4) and has become a cornerstone in the modern management of Hepatitis C.
HEPCINAT PLUS offers a high cure rate, shorter treatment duration, and improved liver function recovery, making it a preferred alternative to brands like Darvoni and Sovodak.
Why Choose HEPCINAT PLUS Daclatasvir + Sofosbuvir?✅ Clinically proven dual therapy for Hepatitis C✅ Effective against major HCV genotypes (1, 3, and 4)✅ Interferon-free, all-oral treatment✅ Once-daily dosing improves compliance✅ Affordable alternative to Darvoni and Sovodak
How It WorksSofosbuvir is a nucleotide polymerase inhibitor targeting the NS5B enzyme, blocking viral RNA replication.
Daclatasvir is an NS5A inhibitor that disrupts HCV replication and viral assembly.
Together, they eliminate the virus from the bloodstream by halting replication at two critical points in the HCV life cycle, offering a highly effective and convenient cure for most patients.
CompositionEach film-coated tablet contains:Sofosbuvir 400 mgDaclatasvir 60 mg
Dosage and AdministrationTake HEPCINAT PLUS as prescribed by your healthcare provider:
One tablet once daily with or without food
Treatment duration typically ranges from 12 to 24 weeks
May be prescribed with ribavirin depending on genotype and liver condition
Swallow the tablet whole with water. Do not chew or split.
Buy HEPCINAT PLUS OnlineOrder HEPCINAT PLUS (Daclatasvir + Sofosbuvir) today from Unnati Pharmax, a trusted global exporter of Hepatitis C medications. We ensure:
✅ Assured quality and authenticity✅ Worldwide shipping with tracking✅ Discreet, secure packaging✅ Competitive rates for bulk and individual orders
FAQs – HEPCINAT PLUS Daclatasvir + Sofosbuvir TabletsQ1: What is HEPCINAT PLUS used for?A1: HEPCINAT PLUS is used to treat chronic Hepatitis C infections, especially genotypes 1, 3, and 4.
Q2: Is HEPCINAT PLUS the same as Darvoni or Sovodak?A2: Yes. HEPCINAT PLUS is a generic version containing the same active ingredients as Darvoni and Sovodak.
Q3: How long does the treatment with HEPCINAT PLUS last?A3: Treatment usually lasts 12–24 weeks depending on the genotype and liver status of the patient.

BILYPSA Saroglitazar Tablets 4 mg – Advanced Therapy for Dyslipidemia & NASH
Brand: BILYPSA
Generic Name: Saroglitazar
Strength: 4 mg
Form: Oral Tablets
Manufacturer: Zydus Healthcare
Availability: In Stock | Ships Worldwide
Exported by: Unnati Pharmax

Product Overview
BILYPSA Saroglitazar Tablets 4 mg is a novel dual PPAR α/γ agonist indicated for the management of diabetic dyslipidemia, hypertriglyceridemia in Type 2 diabetes mellitus, and non-alcoholic steatohepatitis (NASH). It offers a unique therapeutic approach by targeting both lipid and glucose metabolism, making it an important choice for patients with metabolic disorders.

BILYPSA works by modulating the peroxisome proliferator-activated receptors (PPARs), which play a critical role in regulating lipid metabolism, insulin sensitivity, and inflammation. Through this dual action, BILYPSA helps in lowering triglycerides, improving HDL cholesterol, and reducing liver fat accumulation.

Why Choose BILYPSA Saroglitazar?
✅ Clinically proven to manage diabetic dyslipidemia and NASH
✅ Improves both lipid and glycemic parameters
✅ Targets liver fat reduction to address metabolic-associated fatty liver disease
✅ Oral once-daily dosing for patient convenience
✅ Widely accepted and recommended in metabolic care protocols

How It Works
Saroglitazar in BILYPSA acts as a dual PPAR α/γ agonist, stimulating PPAR alpha to reduce triglyceride levels and improve lipid metabolism, while activating PPAR gamma to enhance insulin sensitivity and glucose control. This dual mechanism addresses the underlying metabolic imbalances, reduces cardiovascular risk, and supports liver health.

Composition
Each tablet contains:
Saroglitazar 4 mg

Dosage and Administration
Take BILYPSA as directed by your physician
Usually prescribed as one tablet of 4 mg once daily, with or without food
Swallow the tablet whole with water

Buy BILYPSA Saroglitazar 4 mg Online
Looking for affordable and authentic Saroglitazar tablets online? Order BILYPSA 4 mg today from Unnati Pharmax, your trusted global exporter of specialty and metabolic disorder medications. We ensure:

✅ Genuine, high-quality medicine
✅ Fast and secure worldwide shipping
✅ Discreet packaging for customer privacy
✅ Best-in-market pricing for bulk and retail orders

FAQs – BILYPSA Saroglitazar Tablets 4 mg
Q1: What conditions does BILYPSA treat?
A1: BILYPSA is used for diabetic dyslipidemia, hypertriglyceridemia in Type 2 diabetes, and NASH.

Q2: Can BILYPSA help with fatty liver disease?
A2: Yes, BILYPSA helps reduce liver fat content and inflammation in NASH and NAFLD patients.

Q3: How soon can results be seen?
A3: Improvements in lipid and liver parameters are often observed within a few weeks, but this varies by patient.

Metodox 50mg Injection | Doxorubicin (Plain) 50mg

Advanced Chemotherapy for Solid Tumors and Hematologic Malignancies

📦 Product Overview

Metodox 50mg Injection contains Doxorubicin 50mg, a potent anthracycline antibiotic widely used in chemotherapy for treating various cancers including breast cancer, lymphoma, leukemia, and sarcomas. Manufactured under stringent GMP standards, Metodox is an export-quality formulation providing the same efficacy as Adriamycin® at a competitive price.

Doxorubicin works by intercalating into DNA, inhibiting topoisomerase II, and generating free radicals that induce apoptosis in rapidly dividing cancer cells. It can be used as monotherapy or in combination regimens for enhanced anticancer activity.

⭐ Key Features

✅ Active Ingredient: Doxorubicin 50mg
✅ Anthracycline chemotherapeutic agent
✅ Effective against a wide range of solid and hematologic tumors
✅ Manufactured under strict GMP guidelines
✅ Export-quality, clinically validated formulation

💊 Indications & Uses

Metodox 50mg Injection is indicated for:

✔ Breast cancer
✔ Non-Hodgkin and Hodgkin lymphoma
✔ Acute lymphoblastic and myeloid leukemia
✔ Sarcomas and other solid tumors
✔ Combination chemotherapy regimens (e.g., CHOP, AC, ABVD)

⚙️ Mechanism of Action

Doxorubicin acts by:

🔹 Intercalating into DNA strands
🔹 Inhibiting topoisomerase II, preventing DNA replication
🔹 Generating free radicals that damage cellular membranes and DNA
🔹 Inducing apoptosis in rapidly dividing cancer cells

This mechanism suppresses tumor growth and progression effectively.

⚠ Dosage & Administration

• Administered intravenously under strict medical supervision
• Standard dose: 60–75 mg/m² every 3 weeks or as prescribed
• Dose adjustments may be required for hepatic impairment or previous anthracycline exposure
• Monitor for cardiotoxicity, myelosuppression, and other potential adverse effects

🔸 Common Side Effects

• Nausea and vomiting
• Hair loss (alopecia)
• Myelosuppression (neutropenia, thrombocytopenia)
• Cardiotoxicity with cumulative doses
• Fatigue and mucositis

Seek medical advice if severe or persistent side effects occur.

🌍 Export & Supply

Metodox 50mg Injection is suitable for hospitals, oncology centers, and global pharmaceutical distribution.
Unnati Pharmax ensures:

✅ 100% authentic GMP-certified oncology medication
✅ Secure, export-quality packaging
✅ Fast and reliable worldwide delivery